Can You Drink Alcohol on a GLP‑1? Wegovy, Ozempic, Zepbound and Mounjaro

The prescribing information for Zepbound, Mounjaro, Wegovy and Ozempic does not mention drinking alcohol.1,2,3,4 The only alcohol named in the Zepbound and Mounjaro labels is benzyl alcohol, an inactive ingredient in the multi-dose vial and KwikPen.1,4 The Ozempic and Wegovy instructions mention alcohol only as a swab for cleaning the skin before an injection.2,3

The absence of a warning is not the same as a statement that alcohol is safe. The labels do carry warnings for problems that alcohol can also cause or make worse, and those are the reason a prescriber may ask about drinking.

Wegovy and Ozempic contain semaglutide, and neither label prohibits alcohol, so the decision rests on your health and your prescriber's advice.2,3 The Wegovy label warns that acute pancreatitis has been observed with semaglutide and that hypoglycemia is more likely when it is combined with insulin or an insulin secretagogue.2 Ozempic is approved for adults with type 2 diabetes, a group more likely to take those glucose-lowering drugs.3

Nausea is common on Wegovy. In the adult weight-loss trials, 44% of people on the injection reported nausea, against 16% on placebo, and these reactions were most frequent during dose escalation.2 That is the period when alcohol's effect on the stomach is most likely to add to symptoms already caused by the drug.5

Zepbound and Mounjaro contain tirzepatide, and their labels do not prohibit alcohol either.1,4 The Zepbound label tells prescribers to watch for acute pancreatitis, which can show up as persistent, severe abdominal pain that sometimes spreads to the back, with or without vomiting.1 If pancreatitis is suspected, the label says to stop Zepbound.1

The Zepbound label also says hypoglycemia has been reported in adults without type 2 diabetes, not only in people taking diabetes drugs.1 In a trial of people with type 2 diabetes, low blood sugar occurred in 10.3% of those also taking a sulfonylurea, against 2.1% of those who were not.1 MedlinePlus notes that the risk of low blood sugar from alcohol lasts for hours after the last drink and is greater when people drink without eating.6

Alcohol can lower blood sugar because the liver stops releasing glucose while it processes the alcohol.6 For someone taking insulin or certain other diabetes medicines, MedlinePlus says this can cause seriously low blood sugar.6

Tirzepatide stimulates insulin release in a glucose-dependent way, and every label in this group warns that hypoglycemia is more likely with insulin or a sulfonylurea.1,2,3,4 A GLP-1 can also reduce how much a person eats, and drinking on an empty stomach greatly increases the low-blood-sugar risk from alcohol.6 People with diabetes on these combinations are the group with the most reason to ask a prescriber before drinking.

Acute pancreatitis is a listed warning on every GLP-1 label in this article, and heavy alcohol use is a well-known cause of pancreatitis.1,2,3,4,7 The National Institute of Diabetes and Digestive and Kidney Diseases names gallstones as the most common cause of acute pancreatitis and heavy alcohol use as a common cause of the condition.7

In the Zepbound weight-loss trials, adjudicated acute pancreatitis occurred in 0.2% of people on Zepbound and 0.2% on placebo.1 The labels do not say whether alcohol changes that risk; no study in them tested it.1,2

The GLP-1 labels warn of acute kidney injury, mostly in people who became dehydrated from nausea, vomiting or diarrhea.1,2 The Zepbound label tells patients to take precautions to avoid fluid depletion, and to report persistent nausea, vomiting or diarrhea.1 The joint advisory notes that dehydration from severe gastrointestinal symptoms can cause acute kidney injury and that efforts should be made to prevent it.5

No alcoholic drink is recommended for people taking a GLP-1 medication. No FDA label, and none of the society guidance cited here, names a safer type of drink, a safe number of drinks, or a "best" choice.1,2,5 The joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society lists "minimal alcohol intake" among its eating habits to encourage on GLP-1 therapy.5

The same advisory lists sugar-sweetened beverages among the items to minimize or avoid during GLP-1 treatment.5 Our guide to what to eat on a GLP-1 covers the rest of that advice.

Early research suggests GLP-1 drugs may reduce drinking in some people, but none of these medicines is approved to treat alcohol use disorder.2,8 The evidence so far comes from small trials and observational data:

• A 2025 randomized trial of semaglutide. In 48 adults with alcohol use disorder, 9 weeks of low-dose semaglutide reduced alcohol consumed in a lab drinking session, drinks per drinking day and weekly craving, but did not change average drinks per day or the number of drinking days.8
• A 2024 records study. In 83,825 patients with obesity, semaglutide was associated with a 50% to 56% lower risk of a new or recurrent alcohol use disorder diagnosis over 12 months, compared with other anti-obesity drugs.9 Observational data like this cannot prove cause and effect, and the authors call for randomized trials.9
• A 2022 trial of exenatide. In 127 patients, the older GLP-1 drug exenatide did not reduce heavy drinking days overall, though an exploratory analysis found a reduction in people with a BMI over 30.10

The joint advisory reports that clinicians in its writing group have seen cravings for alcohol diminish in many patients on GLP-1s, and says substance use should be screened for and addressed during treatment.5 For more on how GLP-1s act on reward circuits, see our article on GLP-1s, mental health and cravings.

The labels point to situations where alcohol is a bigger question:1,2,6,7

• You take insulin or a sulfonylurea alongside a GLP-1.
• You have had pancreatitis, or you drink heavily.
• You are in the first weeks of treatment or have just moved up a dose, when nausea and vomiting are most frequent.
• You have kidney disease or have been vomiting or had diarrhea.

Severe abdominal pain that does not go away, with or without vomiting, is a reason to seek care promptly, since the labels list it as a possible sign of pancreatitis.1,2 Our Zepbound side effects and Ozempic side effects guides list the other warning signs.

Can you drink alcohol on Ozempic for weight loss? Ozempic is approved for type 2 diabetes, not weight loss, and its label does not prohibit alcohol.3 People with diabetes who take insulin or a sulfonylurea have a higher risk of low blood sugar when they drink.3,6

Can you drink alcohol on the Wegovy pill? The Wegovy label covers the tablet and the injection together and does not list alcohol as an interaction for either.2 The same pancreatitis, hypoglycemia and kidney warnings apply.2

Does Zepbound help with alcohol cravings? Zepbound is not approved for alcohol use disorder.1 The randomized evidence on cravings so far is for semaglutide, not tirzepatide.8

Does alcohol stop a GLP-1 from working? The labels do not say. None of the FDA prescribing information for these drugs reports a study of alcohol's effect on how well the medicine works.1,2,3,4

Is it safe to drink the day of a GLP-1 injection? The labels give no guidance on timing alcohol around an injection.1,2 They do note that nausea, vomiting and diarrhea are most frequent during dose escalation.1,2

If you are choosing a GLP-1 program and want clinician follow-up for questions like this one, compare options on our best GLP-1 programs ranking or see how the two leading drugs differ in Wegovy vs Zepbound.

This article is for information only and is not medical advice. GLP-1 medications are prescription drugs with real risks and side effects. Talk to a licensed clinician about alcohol use before starting or while taking any treatment.